IT1254627B - Formulazioni di steroidi - Google Patents

Formulazioni di steroidi

Info

Publication number
IT1254627B
IT1254627B ITMI920393A ITMI920393A IT1254627B IT 1254627 B IT1254627 B IT 1254627B IT MI920393 A ITMI920393 A IT MI920393A IT MI920393 A ITMI920393 A IT MI920393A IT 1254627 B IT1254627 B IT 1254627B
Authority
IT
Italy
Prior art keywords
formulation
steroid formulations
steroid
formulations
allergic
Prior art date
Application number
ITMI920393A
Other languages
English (en)
Italian (it)
Inventor
Joy Elaine Saunders
Original Assignee
Fisons
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons filed Critical Fisons
Publication of ITMI920393A0 publication Critical patent/ITMI920393A0/it
Publication of ITMI920393A1 publication Critical patent/ITMI920393A1/it
Application granted granted Critical
Publication of IT1254627B publication Critical patent/IT1254627B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
ITMI920393A 1991-02-23 1992-02-21 Formulazioni di steroidi IT1254627B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919103824A GB9103824D0 (en) 1991-02-23 1991-02-23 Formulation
PCT/GB1992/000290 WO1992014473A1 (en) 1991-02-23 1992-02-19 Steroid formulations

Publications (3)

Publication Number Publication Date
ITMI920393A0 ITMI920393A0 (it) 1992-02-21
ITMI920393A1 ITMI920393A1 (it) 1993-08-21
IT1254627B true IT1254627B (it) 1995-09-28

Family

ID=10690478

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI920393A IT1254627B (it) 1991-02-23 1992-02-21 Formulazioni di steroidi

Country Status (13)

Country Link
CN (1) CN1065010A (el)
AU (1) AU1247192A (el)
BE (1) BE1004177A4 (el)
FR (1) FR2673104A1 (el)
GB (1) GB9103824D0 (el)
GR (1) GR1001511B (el)
IE (1) IE920516A1 (el)
IL (1) IL101010A0 (el)
IT (1) IT1254627B (el)
MX (1) MX9200748A (el)
PT (1) PT100150A (el)
WO (1) WO1992014473A1 (el)
ZA (1) ZA921247B (el)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0551626A1 (en) * 1991-12-19 1993-07-21 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
JP2005281315A (ja) * 1997-07-02 2005-10-13 Aventis Pharmaceuticals Holdings Inc 水性薬理組成物
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US20030059440A1 (en) * 1998-09-01 2003-03-27 Tim Clarot Composition and method for moisturizing nasal tissue
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
DE10064950A1 (de) * 2000-12-23 2002-07-11 Impetus Ag Basel Thixotropes Nasenspray
EP1645266A1 (en) * 2004-10-08 2006-04-12 Hisamitsu Medical Co., Ltd. Aqueous suspension for nasal drops
EP2057982A1 (en) * 2007-11-09 2009-05-13 Archimedes Development Limited Intranasal compositions
WO2013049539A1 (en) * 2011-09-30 2013-04-04 Mcneil-Ppc, Inc. A method of blocking or trapping allergens
EP3694524A1 (en) * 2017-10-11 2020-08-19 Lifescience AS N-acetylneuraminic acid compositions and methods of use
MX2021009595A (es) * 2019-02-11 2021-09-08 Reckitt Benckiser Health Ltd Composicion novedosa.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361559A (en) * 1981-08-20 1982-11-30 E. R. Squibb & Sons, Inc. Antiinflammatory 17,17-bis (substituted thio) androstenes
US4782047A (en) * 1986-05-22 1988-11-01 Syntex Pharmaceuticals International Ltd. Aqueous steroid formulations for nasal administration
US4868170A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steriod lotion formulation
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol

Also Published As

Publication number Publication date
PT100150A (pt) 1993-05-31
IE920516A1 (en) 1992-08-26
AU1247192A (en) 1992-09-15
GB9103824D0 (en) 1991-04-10
WO1992014473A1 (en) 1992-09-03
IL101010A0 (en) 1992-11-15
FR2673104A1 (fr) 1992-08-28
GR1001511B (el) 1994-02-28
ITMI920393A1 (it) 1993-08-21
CN1065010A (zh) 1992-10-07
MX9200748A (es) 1992-10-01
BE1004177A4 (fr) 1992-10-06
ITMI920393A0 (it) 1992-02-21
ZA921247B (en) 1992-10-28

Similar Documents

Publication Publication Date Title
IT1254627B (it) Formulazioni di steroidi
HRP920667B1 (en) Application of fultripine active substance for preventing muscle deformation
GR3036655T3 (en) Use of IL-4 receptors for the therapy, prophylaxis and diagnosis of allergic, viral, paracitic and bacterial diseases, as well as of fungal infections.
AU561016B2 (en) N-glycosylated carboxamide derivatives
ES2063146T3 (es) Composiciones farmaceuticas que contienen acido n-(3,4-dimetoxicinamoil)-antranilico.
DE3381396D1 (de) Formulierung nicht irritierender ophthalmischer waesseriger zusammensetzungen fuer okular-therapeutische mittel.
EP0444196A4 (en) Agent for treatment and prophylaxis of ischemic disease of heart or brain
ES2080297T3 (es) Derivados 17-g(b)-sustituido-4-aza-5g(a)-androstan-3-ona y procedimiento de preparacion de estos.
MY115339A (en) Compositions containing micronized nebivolol
UA37259C2 (uk) Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч
ZA947957B (en) Substituted 1-naphthyl-3-pyrazolecarboxamides which are active in neurotensin their preparation and pharmaceutical compositions containing them
MY131024A (en) Immunostimulating 6-aryl-5, 6-dihydroimidazo [2,1-b] thiazole derivatives.
ZA826453B (en) Tricyclic thiazolyloxamic acids and their derivatives,their preparation,and therapeutic agents containing these compounds
EP0548558A3 (en) Compositions containing surfactants as potentiating agents for the treatment of mammalian diseases
EP0266559A3 (en) Therapeutic agent for the treatment of peptic ulcer disease
MX9204815A (es) Hexahidrobenzo[f]quinolinonas y formulacion farmaceutica que las comprende.
AU5259486A (en) Arylalkoxyphenyl-allylic alcohols as agents for the treatment of hypersensitive ailments
SE8107816L (sv) Medel for lokal behandling av paverkan fran seborre pa menniskans huvudsval
IL87867A0 (en) Preparation of pharmaceutical compositions containing a 2,6-diamino-pyridine derivatives
NO169713C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-arylkarbonyl-1-((4-morfolinyl)alkyl)-1h-indoler.
IT1255696B (it) Composto con attivita' vasodilatatrice procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
EP0402857A3 (en) Use of 17 beta-Cyclopropylaminoandrostene Derivatives
AU3921285A (en) Mefloquine quinates

Legal Events

Date Code Title Description
0001 Granted